2024

1. A genome-wide association meta-analysis of all-cause and vascular dementia

   Alzheimer's and Dementia, Vol. 20, Núm. 9, pp. 5973-5995

2. An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response

   Journal of Alzheimer's Disease, Vol. 98, Núm. 2, pp. 601-618

3. Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission

   npj Parkinson's Disease, Vol. 10, Núm. 1

4. Clinical and Genetic Analysis of Patients With TK2 Deficiency

   Neurology: Genetics, Vol. 10, Núm. 2

5. Copper Overload Increased Rat Striatal Levels of Both Dopamine and Its Main Metabolite Homovanillic Acid in Extracellular Fluid

   International Journal of Molecular Sciences, Vol. 25, Núm. 15

6. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

   Nature Communications

7. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

   Nature Communications

8. Differential blood-based biomarkers of subcortical and deep brain small vessel disease

   Therapeutic Advances in Neurological Disorders, Vol. 17

9. Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance

   Molecular Metabolism, Vol. 79

10. Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain

    Neuropathology and Applied Neurobiology, Vol. 50, Núm. 1

11. Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity

    Journal of Controlled Release, Vol. 372, pp. 295-303

12. Neuroprotective compounds alter the expression of genes coding for proteins related to mitochondrial function in activated microglia

    Mitochondrion, Vol. 78

13. Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models

    Stem Cell Research and Therapy, Vol. 15, Núm. 1

14. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

15. Partial volume correction in longitudinal tau PET studies: is it really needed?

    NeuroImage, Vol. 289

16. Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke

    International Journal of Molecular Sciences, Vol. 25, Núm. 12

17. Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

    iScience, Vol. 27, Núm. 11

18. Quantitative brain [18F]FDG PET beyond normal blood glucose levels

    NeuroImage, Vol. 300

19. The role of the brain renin-angiotensin system in Parkinson´s disease

    Translational Neurodegeneration, Vol. 13, Núm. 1

20. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1